Cliff Asness’s Cidara Therapeutics CDTX Stock Holding History

Cliff Asness’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,699	Closed	-$3.03M	–	3754
2025 Q4	$3.03M	Buy	13,699 +9,941	+265%	+$1.61M	﹤0.01%	1878
2025 Q3	$360K	Buy	+3,758	New	+$240K	﹤0.01%	2986

Cliff Asness's CDTX Position: Q1 2026 in Review

Cliff Asness sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 13,699 shares — an estimated $3.03M sold.

Cliff Asness first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $3.03M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Cliff Asness reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Cliff Asness sold 13,699 Cidara Therapeutics shares in Q1 2026, an estimated $3.03M.
Cliff Asness first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Cliff Asness's Cidara Therapeutics position peaked at $3.03M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.